Cargando…

Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model

BACKGROUND: All-trans retinoic acid (ATRA, tretinoin) is a vitamin A derivative commonly used in the treatment of diverse conditions ranging from cancer to acne. In a fraction of predisposed individuals, the administration of ATRA is accompanied by variety of adverse metabolic effects, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: Krupková, Michaela, Liška, František, Šedová, Lucie, Křenová, Drahomíra, Křen, Vladimír, Šeda, Ondřej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247747/
https://www.ncbi.nlm.nih.gov/pubmed/25403085
http://dx.doi.org/10.1186/1476-511X-13-172
_version_ 1782346696616837120
author Krupková, Michaela
Liška, František
Šedová, Lucie
Křenová, Drahomíra
Křen, Vladimír
Šeda, Ondřej
author_facet Krupková, Michaela
Liška, František
Šedová, Lucie
Křenová, Drahomíra
Křen, Vladimír
Šeda, Ondřej
author_sort Krupková, Michaela
collection PubMed
description BACKGROUND: All-trans retinoic acid (ATRA, tretinoin) is a vitamin A derivative commonly used in the treatment of diverse conditions ranging from cancer to acne. In a fraction of predisposed individuals, the administration of ATRA is accompanied by variety of adverse metabolic effects, particularly by the induction of hyperlipidemia. We have previously derived a minimal congenic SHR.PD-(D8Rat42-D8Arb23)/Cub (SHR-Lx) strain sensitive to ATRA-induced increase of triacylglycerols and cholesterol under condition of high-sucrose diet. SHR-Lx differs only by 7 genes of polydactylous rat (PD/Cub) origin from its spontaneously hypertensive rat (SHR) progenitor strain. METHODS: Adult male rats of SHR and SHR-Lx strains were fed standard diet (STD) and experimental groups were subsequently treated with ATRA (15 mg/kg) via oral gavage for 16 days, while still on STD. We contrasted the metabolic profiles (including free fatty acids, triacylglycerols (TG) and cholesterol (C) in 20 lipoprotein fractions) between SHR and SHR-Lx under conditions of standard diet and standard diet + ATRA. We performed transcriptomic analysis of muscle tissue (m. soleus) in all groups using Affymetrix GeneChip Rat Gene 2.0 ST Arrays followed by Ingenuity Pathway Analysis and real-time PCR validation. RESULTS: In response to ATRA, SHR-Lx reacted with substantially greater rise in TG and C concentrations throughout the lipoprotein spectrum (two-way ANOVA strain * RA interaction significant for C content in chylomicrons (CM), VLDL and LDL as well as total, CM and HDL-TG). CONCLUSIONS: According to our modeling of metabolic and signalization pathways using differentially expressed genes we have identified a network with major nodes (including Sirt3, Il1b, Cpt1b and Pparg) likely to underlie the observed strain specific response to ATRA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-511X-13-172) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4247747
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42477472014-11-30 Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model Krupková, Michaela Liška, František Šedová, Lucie Křenová, Drahomíra Křen, Vladimír Šeda, Ondřej Lipids Health Dis Research BACKGROUND: All-trans retinoic acid (ATRA, tretinoin) is a vitamin A derivative commonly used in the treatment of diverse conditions ranging from cancer to acne. In a fraction of predisposed individuals, the administration of ATRA is accompanied by variety of adverse metabolic effects, particularly by the induction of hyperlipidemia. We have previously derived a minimal congenic SHR.PD-(D8Rat42-D8Arb23)/Cub (SHR-Lx) strain sensitive to ATRA-induced increase of triacylglycerols and cholesterol under condition of high-sucrose diet. SHR-Lx differs only by 7 genes of polydactylous rat (PD/Cub) origin from its spontaneously hypertensive rat (SHR) progenitor strain. METHODS: Adult male rats of SHR and SHR-Lx strains were fed standard diet (STD) and experimental groups were subsequently treated with ATRA (15 mg/kg) via oral gavage for 16 days, while still on STD. We contrasted the metabolic profiles (including free fatty acids, triacylglycerols (TG) and cholesterol (C) in 20 lipoprotein fractions) between SHR and SHR-Lx under conditions of standard diet and standard diet + ATRA. We performed transcriptomic analysis of muscle tissue (m. soleus) in all groups using Affymetrix GeneChip Rat Gene 2.0 ST Arrays followed by Ingenuity Pathway Analysis and real-time PCR validation. RESULTS: In response to ATRA, SHR-Lx reacted with substantially greater rise in TG and C concentrations throughout the lipoprotein spectrum (two-way ANOVA strain * RA interaction significant for C content in chylomicrons (CM), VLDL and LDL as well as total, CM and HDL-TG). CONCLUSIONS: According to our modeling of metabolic and signalization pathways using differentially expressed genes we have identified a network with major nodes (including Sirt3, Il1b, Cpt1b and Pparg) likely to underlie the observed strain specific response to ATRA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1476-511X-13-172) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-17 /pmc/articles/PMC4247747/ /pubmed/25403085 http://dx.doi.org/10.1186/1476-511X-13-172 Text en © Krupková et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Krupková, Michaela
Liška, František
Šedová, Lucie
Křenová, Drahomíra
Křen, Vladimír
Šeda, Ondřej
Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title_full Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title_fullStr Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title_full_unstemmed Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title_short Pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
title_sort pharmacogenomic analysis of retinoic-acid induced dyslipidemia in congenic rat model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247747/
https://www.ncbi.nlm.nih.gov/pubmed/25403085
http://dx.doi.org/10.1186/1476-511X-13-172
work_keys_str_mv AT krupkovamichaela pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel
AT liskafrantisek pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel
AT sedovalucie pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel
AT krenovadrahomira pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel
AT krenvladimir pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel
AT sedaondrej pharmacogenomicanalysisofretinoicacidinduceddyslipidemiaincongenicratmodel